Macular Edema: all 848 studies

Page 2 of 9. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTACompletedNCT03246152Phase 4Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVOTerminatedNCT03203447Phase 3Results posted
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular EdemaCompletedNCT03126786Phase 2Results posted
• Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg LucentisCompletedNCT03097068Phase 4Results posted
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT03093701Phase 2Results posted
• Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus PlaceboCompletedNCT03025945Not applicableResults posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOTerminatedNCT02980874Phase 3Results posted
• Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyCompletedNCT02953938Phase 4Results posted
• Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal InjectionsCompletedNCT02951351Not applicableResults posted
• Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular EdemaCompletedNCT02949024Phase 1/2Results posted
• Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)CompletedNCT02914613Phase 1/2Results posted
• Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic RetinopathyCompletedNCT02834663Phase 4Results posted
• Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)CompletedNCT02818998Phase 3Results posted
• Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVOCompletedNCT02800642Phase 4Results posted
• Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsCompletedNCT02764697Phase 4Results posted
• Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular EdemaCompletedNCT02732951Phase 2Results posted
• Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular EdemaCompletedNCT02712008Phase 2Results posted
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular EdemaCompletedNCT02699450Phase 2Results posted
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)CompletedNCT02698566Phase 3Results posted
• Influence of Diabetes Control on Treatment of Diabetic Macular Edema With RanibizumabTerminatedNCT02665689Phase 4Results posted
• Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) StudyCompletedNCT02661711Phase 2Results posted
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialCompletedNCT02623426Phase 3Results posted
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisCompletedNCT02595398Phase 3Results posted
• Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.CompletedNCT02581995Phase 4Results posted
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.CompletedNCT02571972Phase 2Results posted
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or BevacizumabCompletedNCT02559180Phase 4Results posted
• SD-OCT AngiographyTerminatedNCT02510885Not applicableResults posted
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVOCompletedNCT02503540Phase 4Results posted
• A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid TherapyCompletedNCT02472366Phase 4Results posted
• Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular EdemaCompletedNCT02471651Phase 4Results posted
• The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid ExudatesCompletedNCT02448446Phase 1/2Results posted
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema TrialCompletedNCT02374060Phase 3Results posted
• Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DMECompletedNCT02363621Phase 2Results posted
• Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular EdemaCompletedNCT02348918Phase 2Results posted
• Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)TerminatedNCT02338973Phase 1/2Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOCompletedNCT02303184Phase 2Results posted
• Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME TrialCompletedNCT02299336Phase 4Results posted
• Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DMECompletedNCT02262260Phase 3Results posted
• A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) PatientsCompletedNCT02259088Phase 3Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisCompletedNCT02255032Phase 2Results posted
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular EdemaCompletedNCT02245516Not applicableResults posted
• Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®CompletedNCT02181530Results posted
• Near Infrared Photobiomodulation Treatment for Diabetic Macular OedemaCompletedNCT02181400Not applicableResults posted
• Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.CompletedNCT02140411Phase 4Results posted
• Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis PigmentosaCompletedNCT02140164Phase 1/2Results posted
• A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular EdemaCompletedNCT02121262Phase 3Results posted
• Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGFCompletedNCT02118831Phase 1/2Results posted
• Performance Assessment Tests in Working Individuals With DME Following Treatment With RanibizumabCompletedNCT02107131Phase 4Results posted
• Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available TherapiesTerminatedNCT02080091Results posted
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular EdemaCompletedNCT02036424Phase 4Results posted
• Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula EdemaTerminatedNCT02032238Not applicableResults posted
• Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment PhaseTerminatedNCT02032173Phase 3Results posted
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVOCompletedNCT02006147Phase 1/2Results posted
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular EdemaTerminatedNCT01994291Phase 2Results posted
• Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract SurgeryCompletedNCT01988246Phase 1/2Results posted
• Safety and Efficacy of Ranibizumab for Diabetic Macular EdemaCompletedNCT01982435Phase 1/2Results posted
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01976338Phase 3Results posted
• Diabetic Macular Edema Treated With Ozurdex (DMEO)CompletedNCT01951066Phase 2Results posted
• Phase II Combination Steroid and Anti-VEGF for Persistent DMECompletedNCT01945866Phase 2Results posted
• A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular EdemaCompletedNCT01934556Phase 1/2Results posted
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular EdemaCompletedNCT01918371Results posted
• Treatment for CI-DME in Eyes With Very Good VA StudyCompletedNCT01909791Phase 3Results posted
• An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.CompletedNCT01908816Phase 3Results posted
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein OcclusionCompletedNCT01903720Phase 4Results posted
• Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg DexamethasoneCompletedNCT01892163Phase 3Results posted
• OCT Screening for Diabetic Macular Edema at Primary Diabetes Care VisitsCompletedNCT01875783Not applicableResults posted
• To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular EdemaCompletedNCT01846299Phase 3Results posted
• A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.CompletedNCT01821677Phase 2Results posted
• A Retrospective Chart Review of OZURDEX® in Patients With Macular EdemaCompletedNCT01805323Results posted
• Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy SurgeryTerminatedNCT01788475Not applicableResults posted
• Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central InvolvementCompletedNCT01783886Phase 3Results posted
• Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)CompletedNCT01769352Phase 2/3Results posted
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOCompletedNCT01692938Results posted
• A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes MellitusCompletedNCT01673191Phase 2Results posted
• Bloodstream Absorption of Avastin and Lucentis After Injection Into the EyeCompletedNCT01661946Phase 3Results posted
• Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)CompletedNCT01660802Phase 3Results posted
• Anesthesia Preference for Intravitreal Injection: Topical or SubconjunctivalCompletedNCT01640171Not applicableResults posted
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaCompletedNCT01627249Phase 3Results posted
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein OcclusionCompletedNCT01618266Results posted
• Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)CompletedNCT01613716Phase 4Results posted
• Ranibizumab and Bevacizumab for Diabetic Macular EdemaCompletedNCT01610557Phase 2Results posted
• Extension Study to Gather Data on Effect of Macugen on the Corneal EndotheliumCompletedNCT01573572Phase 4Results posted
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01571557Results posted
• Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaCompletedNCT01571232Phase 2Results posted
• Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedNCT01568021Results posted
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionCompletedNCT01566526Results posted
• A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)TerminatedNCT01565148Phase 2Results posted
• Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)CompletedNCT01552408Phase 1/2Results posted
• Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular EdemaCompletedNCT01546402Phase 4Results posted
• Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionCompletedNCT01535261Phase 3Results posted
• Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular EdemaCompletedNCT01492400Phase 2Results posted
• Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) StudyCompletedNCT01486238Phase 4Results posted
• Dosing Study of Ranibizumab for Diabetic Retinal and Macular EdemaCompletedNCT01476449Phase 2Results posted
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving BevacizumabCompletedNCT01471691Phase 1/2Results posted
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal MelanomaTerminatedNCT01471054Phase 2Results posted
• Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.CompletedNCT01449682Phase 3Results posted
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)CompletedNCT01445626Results posted
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)CompletedNCT01442064Not applicableResults posted
• Dextromethorphan for Diabetic Macular EdemaCompletedNCT01441102Phase 1/2Results posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted

← Macular Edema overview